Prof. Dr. SEVİM ERDEM ÖZDAMAR

Yayın Ağı

Makaleler 62

1. Random X chromosome inactivation in female Charcot-Marie-Tooth disease type X1: insights from sural nerve biopsy analysis

KURT C. E., Aksu-Menges E., Kumtepe E. T., DURMAZ ÖZDİNÇ C. D., Terzi Y. K., ERGÜL ÜLGER Z., et al.

BMC NEUROLOGY , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

2. Home infusion experience in patients with Pompe disease receiving avalglucosidase alfa during three clinical trials

Diaz-Manera J., Hughes D., Erdem-Ozdamar S., Tard C., Behin A., Bouhour F., et al.

MOLECULAR GENETICS AND METABOLISM , cilt.143, sa.4, 2024 (SCI-Expanded, Scopus)

3. A novel pathogenic PTRH2 variant indicates seizure association with protein-truncating variants in Infantile-Onset Multisystem Neurologic, Endocrine and Pancreatic Disease (IMNEPD)

AKÇİN Ö. Ç., KURTÇU O., DERİCİOĞLU N., ERDEM ÖZDAMAR S., KURT C. E., ALTINER Ş., et al.

EUROPEAN JOURNAL OF HUMAN GENETICS , ss.1494, 2024 (SCI-Expanded, Scopus)

4. Effect of Follicular T Helper and T Helper 17 Cells-Related Molecules on Disease Severity in Patients with Myasthenia Gravis

ARSLAN D., ERGÜL ÜLGER Z., Goksen S., ESENDAĞLI G., ERDEM ÖZDAMAR S., Tan E., et al.

EUROPEAN NEUROLOGY , cilt.87, sa.5-6, ss.223-229, 2024 (SCI-Expanded, Scopus)

5. Clinical and laboratory remission with rituximab in anti-MuSK-positive myasthenia gravis

İNAN B., ORHAN İ. G., KURT C. E., ERDEM ÖZDAMAR S., Tan E.

IRISH JOURNAL OF MEDICAL SCIENCE , cilt.193, ss.2989-2994, 2024 (SCI-Expanded, Scopus)

6. **A novel pathogenic PTRH2 variant indicates seizure association with protein-truncating variants in Infantile-Onset Multisystem Neurologic, Endocrine and Pancreatic Disease (IMNEPD)**

AKÇİN Ö. Ç., KURTÇU O., DERİCİOĞLU N., ERDEM ÖZDAMAR S., KURT C. E., ALTINER Ş., et al.

EUROPEAN JOURNAL OF HUMAN GENETICS , ss.1494, 2024 (SCI-Expanded, Scopus)

7. Differentiating recurrent Guillain-Barre syndrome and acute-onset chronic inflammatory polyneuropathy: literature review

İNAN B., KURT C. E., Demirci M., ERDEM ÖZDAMAR S., Tan E.

ACTA NEUROLOGICA BELGICA , cilt.124, ss.1467-1475, 2024 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

8. VARIABLE PHENOTYPE IN FEMALES WITH HETEROZYGOUS GJB1 MUTATION

KURT C. E., ERGÜL ÜLGER Z., TEMUÇİN Ç. M., Kumtepe E. T., BALCI B., Tan E., et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , 2024 (SCI-Expanded, Scopus)

9. Recurrent simultaneous central nervous system demyelination with possible peripheral demyelination / nodopathy in a seronegative patient

İNAN B., KURT C. E., YILDIZ SARIKAYA F. G., GÖÇMEN R., TEMUÇİN Ç. M., Tuncer A., et al.

IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE , cilt.77, sa.9-10, ss.357-360, 2024 (SCI-Expanded, Scopus)

10. Nusinersen for adults with spinal muscular atrophy

ARSLAN D., İNAN B., KILINÇ M., Bekircan-Kurt C. E., ERDEM ÖZDAMAR S., Tan E.

Neurological Sciences , cilt.44, sa.7, ss.2393-2400, 2023 (SCI-Expanded, Scopus)

11. Efficacy and Safety of Avalglucosidase Alfa in Patients with Late-Onset Pompe Disease after 97 Weeks: A Phase 3 Randomized Clinical Trial

Kishnani P. S., Diaz-Manera J., Toscano A., Clemens P. R., Ladha S., Berger K. I., et al.

JAMA Neurology , cilt.80, sa.6, ss.558-567, 2023 (SCI-Expanded, Scopus)

12. The evaluation of small fibers in multiple sclerosis

Bekircan-Kurt C. E., Jahanroshan J., Tuncer A., ERGÜL ÜLGER Z., Gunes G., ERDEM ÖZDAMAR S., et al.

Multiple Sclerosis and Related Disorders , cilt.72, 2023 (SCI-Expanded, Scopus)

13. Expert opinion on the diagnostic odyssey and management of late-onset Pompe disease: a neurologist's perspective

ERDEM ÖZDAMAR S., KOÇ A. F., Durmus Tekce H., Kotan D., Ekmekci A. H., ŞENGÜN İ. Ş., et al.

Frontiers in Neurology , cilt.14, 2023 (SCI-Expanded, Scopus)

14. Efficacy and safety of Avalglucosidase Alfa in participants with late-onset Pompe Disease after 145 weeks' treatment during the COMET trial

Schoser B., Kishnani P., Kushlaf H., Ladha S., Mozaffar T., Straub V., et al.

NEUROMUSCULAR DISORDERS , cilt.32, 2022 (SCI-Expanded, Scopus)

15. COMET: Efficacy and safety of avalglucosidase alfa in late-onset Pompe disease participants after 97 weeks of treatment

Schoser B., Kishnani P., Diaz-Manera J., Kushlaf H., Ladha S., Mozaffar T., et al.

EUROPEAN JOURNAL OF NEUROLOGY , cilt.29, ss.59-60, 2022 (SCI-Expanded, Scopus)

16. Home-infusion experience in patients with Pompe disease receiving avalglucosidase alfa during three clinical trials (COMET, NEO-EXT, and Mini-COMET)

Daz-Manera J., Hughes D., Behin A., Bouhour F., Davison J., ERDEM ÖZDAMAR S., et al.

MOLECULAR GENETICS AND METABOLISM , cilt.135, sa.2, 2022 (SCI-Expanded, Scopus)

17. The avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients: Efficacy and safety results after 97 weeks

Kishnani P., Diaz-Manera J., Kushlaf H., Ladha S., Mozaffar T., Straub V., et al.

MOLECULAR GENETICS AND METABOLISM , cilt.135, sa.2, 2022 (SCI-Expanded, Scopus)

18. Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients

Kishnani P. S., Attarian S., Borges J. L., Bouhourd F., Chien Y., Choi Y., et al.

MOLECULAR GENETICS AND METABOLISM , cilt.132, sa.2, 2021 (SCI-Expanded, Scopus)

19. Comprehensive clinical, biochemical, radiological and genetic analysis of 28 Turkish cases with suspected metachromatic leukodystrophy and their relatives

Pekgul F., Eroglu-Ertugrul N. G., Bekircan-Kurt C. E., Erdem-Ozdamar S., Cetinkaya A., Tan E., et al.

MOLECULAR GENETICS AND METABOLISM REPORTS , cilt.25, 2020 (SCI-Expanded, Scopus)

20. Laboratory diagnosis of metachromatic leukodystrophy requires more than arylsulfatase A assay

Pekgul F., Bekircan-Kurt C. E., Konuskan B., Erdem-Ozdamar S., Tan E., Akarsu N., et al.

FEBS OPEN BIO , cilt.9, ss.199, 2019 (SCI-Expanded, Scopus)

21. Novel SBF2 mutations and clinical spectrum of Charcot-Marie-Tooth neuropathy type 4B2

Lassuthova P., Vill K., Erdem-Ozdamar S., Schroeder J. M., Topaloglu H., Horvath R., et al.

CLINICAL GENETICS , cilt.94, sa.5, ss.467-472, 2018 (SCI-Expanded, Scopus)

22. Establishment of primary myoblast cell cultures from cryopreserved skeletal muscle biopsies to serve as a tool in related research & development studies

Balci-Hayta B., Bekircan-Kurt C. E., AKSU MENGEŞ E., DAYANGAÇ ERDEN D., Tan E., ERDEM ÖZDAMAR S.

JOURNAL OF THE NEUROLOGICAL SCIENCES , cilt.393, ss.100-104, 2018 (SCI-Expanded, Scopus)

23. The histopathological evaluation of small fiber neuropathy in patients with vitamin B12 deficiency

Gunes H. N., Bekircan-Kurt C. E., Tan E., ERDEM ÖZDAMAR S.

ACTA NEUROLOGICA BELGICA , cilt.118, sa.3, ss.405-410, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Ocular surface alterations and in vivo confocal microscopic characteristics of corneas in patients with myasthenia gravis

ERKAN TURAN K., KOCABEYOĞLU S., Bekircan-Kurt C. E., BEZCİ F., ERDEM ÖZDAMAR S., Irkec M.

EUROPEAN JOURNAL OF OPHTHALMOLOGY , cilt.28, sa.5, ss.541-546, 2018 (SCI-Expanded, Scopus)

25. Do Perineuronal Net Elements Contribute to Pathophysiology of Spinal Muscular Atrophy? In Vitro and Transcriptomics Insights

DAYANGAÇ ERDEN D., GÜR DEDEOĞLU B., Eskici F. N., Oztemur-Islakoglu Y., ERDEM ÖZDAMAR S.

OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY , cilt.22, sa.9, ss.598-606, 2018 (SCI-Expanded, Scopus)

26. A rare cause of proximal muscle weakness: immune necrotising myopathy

GÜVEN D. C., ERDEN A., KILIÇ L., ERDEM ÖZDAMAR S., KARADAĞ Ö.

SCOTTISH MEDICAL JOURNAL , cilt.63, sa.3, ss.82-86, 2018 (SCI-Expanded, Scopus)

27. A database for screening and registering late onset Pompe disease in Turkey

Gokyigit M. C., Ekmekci H., Durmus H., Karll N., KÖSEOĞLU E., Aysal F., et al.

NEUROMUSCULAR DISORDERS , cilt.28, sa.3, ss.262-267, 2018 (SCI-Expanded, Scopus)

28. The altered expression of perineuronal net elements during neural differentiation

Eskici N. F., ERDEM ÖZDAMAR S., DAYANGAÇ ERDEN D.

CELLULAR & MOLECULAR BIOLOGY LETTERS , cilt.23, 2018 (SCI-Expanded, Scopus)

29. Recent therapeutic developments in spinal muscular atrophy

BORA G., YEŞBEK KAYMAZ A., Bekircan Kurt C. E., HALİLOĞLU V. G., TOPALOĞLU H. A., Erdem Yurter H., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.48, sa.2, ss.203-211, 2018 (SCI-Expanded, Scopus, TRDizin)

30. Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle disease

Inal-Gultekin G., Toptas-Hekimoglu B., Gormez Z., Gelisin O., Durmus H., Erguner B., et al.

NEUROMUSCULAR DISORDERS , cilt.27, sa.11, ss.997-1008, 2017 (SCI-Expanded, Scopus)

31. New mutations and genotype-phenotype correlation in late-onset Pompe patients

Bekircan-Kurt C. E., Gunes H. N., Yildiz F. G., SAKA TOPÇUOĞLU E., Tan E., ERDEM ÖZDAMAR S.

ACTA NEUROLOGICA BELGICA , cilt.117, sa.1, ss.269-275, 2017 (SCI-Expanded, Scopus)

32. Transcript levels of plastin 3 and neuritin 1 modifier genes in spinal muscular atrophy siblings

Yener I. H., Topaloglu H., ERDEM ÖZDAMAR S., DAYANGAÇ ERDEN D.

PEDIATRICS INTERNATIONAL , cilt.59, sa.1, ss.53-56, 2017 (SCI-Expanded, Scopus)

33. Dysferlinopathy: A Case Report and Literature Update

Kutlu O., KURT C. E., Unsal I., Aribas Z., Renkliyildiz B., Eruzun H., et al.

ISTANBUL MEDICAL JOURNAL , cilt.17, sa.4, ss.136-140, 2016 (ESCI, TRDizin)

34. Autoimmune storm

Aslan S., Bekircan-Kurt C. E., Kurne A. T., Erdem-Ozdamar S.

EUROPEAN JOURNAL OF NEUROLOGY , cilt.23, ss.437, 2016 (SCI-Expanded, Scopus)

35. The evaluation of small fibres in asymptomatic patients with Val30Met mutation

Bekircan-Kurt C. E., Yildiz F. G., Gunes H. N., Erdem-Ozdamar S., Tan E.

EUROPEAN JOURNAL OF NEUROLOGY , cilt.23, ss.231, 2016 (SCI-Expanded, Scopus)

36. Spinal muscular atrophy type III: Molecular genetic characterization of Turkish patients

BORA-TATAR G., YESBEK-KAYMAZ A., BEKIRCAN-KURT C. E., ERDEM-OZDAMAR S., Erdem-Yurter H.

EUROPEAN JOURNAL OF MEDICAL GENETICS , cilt.58, sa.12, ss.654-658, 2015 (SCI-Expanded, Scopus)

37. Three Turkish families with different transthyretin mutations

Bekirean-Kurt C. E., GUNES N., Yilmaz A., ERDEM-OZDAMAR S., TAN E.

NEUROMUSCULAR DISORDERS , cilt.25, sa.9, ss.686-692, 2015 (SCI-Expanded, Scopus)

38. Proinflammatory effect of AbetaPP induced ST6GAL1 secretion from C2C12 myogenic cell line

HAYTA B., ERDEM ÖZDAMAR S., Dincer P.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.40, sa.1, ss.31-36, 2015 (SCI-Expanded, Scopus, TRDizin)

39. Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach

Zimon M., BATTALOĞLU E., Parman Y., Erdem S., Baets J., De Vriendt E., et al.

NEUROGENETICS , cilt.16, sa.1, ss.33-42, 2015 (SCI-Expanded, Scopus)

40. REMISSION WITH FINGOLIMOD IN A CASE OF DEMYELINATING POLYNEUROPATHY

ERDENER Ş. E., NURLU G., GÖÇMEN R., Erdem-Ozdamar S., KURNE A.

MUSCLE & NERVE , cilt.50, sa.4, ss.615-617, 2014 (SCI-Expanded, Scopus)

41. The Course of Myasthenia Gravis with Systemic Lupus Erythematosus

Bekircan-Kurt C. E., Kurne A. T., Erdem-Ozdamar S., Kalyoncu U., Karabudak R., Tan E.

EUROPEAN NEUROLOGY , cilt.72, ss.326-329, 2014 (SCI-Expanded, Scopus)

42. A novel desmin mutation leading to autosomal recessive limb-girdle muscular dystrophy: distinct histopathological outcomes compared with desminopathies

Cetin N., Balci-Hayta B., Gundesli H., KORKUSUZ P., PURALI N., TALİM B., et al.

JOURNAL OF MEDICAL GENETICS , cilt.50, sa.7, ss.437-443, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

43. Myasthenia Gravis; Single Entity, Variable Clinical Features: Ten Years of Clinical Experience in a Tertiary Care Center Ten Years Clinical Experience of a Tertiary Care Center

BEKIRCAN-KURT C. E., KURNE A., ERDEM ÖZDAMAR S., KARABUDAK R., KANSU T., TAN E.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH , cilt.30, sa.1, ss.135-143, 2013 (SCI-Expanded, Scopus, TRDizin)

44. Identification of a Novel Twinkle Mutation in a Family With Infantile Onset Spinocerebellar Ataxia by Whole Exome Sequencing

DUNDAR H., ÖZGÜL R. K., YALNIZOĞLU D., Erdem S., Oguz K. K., Tuncel D., et al.

PEDIATRIC NEUROLOGY , cilt.46, sa.3, ss.172-177, 2012 (SCI-Expanded, Scopus)

45. Diabetic muscular infarct: an unusual cause of extremity pain and dysfunction

Ucan H., Alemdaroglu E., Yoldas T. K., ERDEM ÖZDAMAR S., Akyuz M., Hatipoglu C.

RHEUMATOLOGY INTERNATIONAL , cilt.32, sa.2, ss.525-528, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

46. Overexpression of amyloid beta precursor protein enhances expression and secretion of ST6Gal1 in C2C12 myogenic cell line

BALCI-HAYTA B., Erdem-Ozdamar S., DINCER P. R.

CELL BIOLOGY INTERNATIONAL , cilt.35, sa.1, ss.9-13, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. Early Diagnosis of Distal Peripheral Polyneuropathy Due to Glucose Metabolism Disorders via Intraepidermal Nerve Fiber Analysis

Kursun O., KARATAŞ KURŞUN H., ULUÇ K., ERDEM ÖZDAMAR S., Erbas T., Tan E.

TURKISH JOURNAL OF NEUROLOGY , cilt.15, sa.1, ss.24-30, 2009 (ESCI, TRDizin) Sürdürülebilir Kalkınma

48. Nuclear morphometric analysis in gastrointestinal stromal tumors: A preliminary study

ÖZDAMAR Ş. O., Bektas S., ERDEM ÖZDAMAR S., Gedikoglu G., DOĞAN GÜN B., BAHADIR B.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.18, sa.2, ss.71-76, 2007 (SCI-Expanded, Scopus, TRDizin)

49. Calpain-3 mutations in Turkey

Balci B., Aurino S., Haliloglu G., Talim B., Erdem S., Akcoren Z., et al.

EUROPEAN JOURNAL OF PEDIATRICS , cilt.165, sa.5, ss.293-298, 2006 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

50. Giant axonal neuropathy: clinical and genetic study in six cases

DEMIR E., BOMONT P., ERDEM S., CAVALIER L., DEMIRCI M., KOSE G., et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , cilt.76, sa.6, ss.825-832, 2005 (SCI-Expanded, Scopus)

51. Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy

Senderek J., Bergmann C., Stendel C., Kirfel J., Verpoorten N., De Jonghe P., et al.

AMERICAN JOURNAL OF HUMAN GENETICS , cilt.73, sa.5, ss.1106-1119, 2003 (SCI-Expanded, Scopus)

52. Four novel thymidine phosphorylase gene mutations in mitochondrial neurogastrointestinal encephalomyopathy syndrome (MNGIE) patients

Kocaefe Y. Ç., Erdem S., Ozguc M., Tan E.

EUROPEAN JOURNAL OF HUMAN GENETICS , cilt.11, sa.1, ss.102-104, 2003 (SCI-Expanded, Scopus)

53. Mutations in GDAP1 - Autosomal recessive CMT with demyelination and axonopathy

Nelis E., Erdem S., Van den Bergh P., Belpaire-Dethiou M., Ceuterick C., Van Gerwen V., et al.

NEUROLOGY , cilt.59, sa.12, ss.1865-1872, 2002 (SCI-Expanded, Scopus)

54. A novel homozygous missense mutation in the myotubularin-related protein 2 gene associated with recessive Charcot-Marie-Tooth disease with irregularly folded myelin sheaths

Nelis E., Erdem S., Tan E., Lofgren A., Ceuterick C., De Jonghe P., et al.

NEUROMUSCULAR DISORDERS , cilt.12, sa.9, ss.869-873, 2002 (SCI-Expanded, Scopus)

55. Exercise-induced apoptosis of rat skeletal muscle and the effect of meloxicam

Arslan S., Erdem S., Sivri A., Hascelik Z., Tan E.

RHEUMATOLOGY INTERNATIONAL , cilt.21, sa.4, ss.133-136, 2002 (SCI-Expanded, Scopus)

56. Cremaster muscle is not sexually dimorphic, but that from boys with undescended testis reflects alterations related to autonomic innervation

Tanyel F. C., Erdem S., Buyukpamukcu N., Tan E.

JOURNAL OF PEDIATRIC SURGERY , cilt.36, sa.6, ss.877-880, 2001 (SCI-Expanded, Scopus)

57. Cremaster muscles obtained from boys with an undescended testis show significant neurological changes

Tanyel F. C., Erdem S., Buyukpamukcu N., Tan E.

BJU INTERNATIONAL , cilt.85, sa.1, ss.116-119, 2000 (SCI-Expanded, Scopus)

58. Painful sensory neuropathy: Prospective evaluation using skin biopsy

Periquet M., Novak V., Collins M., Nagaraja H., ERDEM ÖZDAMAR S., Nash S., et al.

Neurology , cilt.53, sa.8, ss.1641-1647, 1999 (SCI-Expanded, Scopus)

59. Compartmental changes in expression of c-Fos and FosB proteins in intact and dopamine-depleted striatum after chronic apomorphine treatment

Saka E., ELİBOL B., ERDEM ÖZDAMAR S., Dalkara T.

Brain Research , cilt.825, sa.1-2, ss.104-114, 1999 (SCI-Expanded, Scopus)

60. Fate of Schwann cells in CMT1A and HNPP: Evidence for apoptosis

ERDEM ÖZDAMAR S., Mendell J. R., Sahenk Z.

Journal of Neuropathology and Experimental Neurology , cilt.57, sa.6, ss.635-642, 1998 (SCI-Expanded, Scopus)

61. Late onset muscular dystrophy with cerebral white matter changes due to partial merosin deficiency

Tan E., Topaloglu H., Sewry C., Zorlu Y., Naom I., ERDEM ÖZDAMAR S., et al.

Neuromuscular Disorders , cilt.7, sa.2, ss.85-89, 1997 (SCI-Expanded, Scopus)

62. Alexia without either agraphia or hemianopia in temporal lobe lesion due to herpes simplex encephalitis.

Erdem S., Kansu T.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society , cilt.15, sa.2, ss.102-4, 1995 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 37

1. MİYASTENİK KRİZ İLE BAŞVURAN HASTALARDA YARDIMCI FOLİKÜLER T HÜCRE (TFH) VE YARDIMCI T HÜCRE 17 (TH17) İLİŞKİLİ SİTOKİNLERİN TEDAVİ ÖNCESİ VE SONRASI DEĞİŞKENLİĞİ

ARSLAN D., ERGÜL ÜLGER Z., gökşen s., ESENDAĞLI G., ERDEM ÖZDAMAR S., TAN M. E., et al.

59. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 Aralık 2023, (Özet Bildiri)

2. NUSİNERSEN TEDAVİSİ ALAN ERİŞKİN SPİNAL MUSKÜLER ATROFİ HASTALARINDA İNFLAMASYON VE GLİAL HÜCRE İLİŞKİLİ BİYOBELİRTEÇLERİN TESPİTİ

ARSLAN D., ERGÜL ÜLGER Z., gökşen s., ESENDAĞLI G., ERDEM ÖZDAMAR S., TAN M. E., et al.

59. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 13 Aralık 2023, (Özet Bildiri)

3. Evaluation of the Role of Glial Factors in the Pathogenesis of Spinal Muscular Atrophy

ARSLAN D., ERGÜL ÜLGER Z., gökşen s., İNAN B., ESENDAĞLI G., ERDEM ÖZDAMAR S., et al.

2023 Neuromuscular Study Group Meeting, Orlando, Amerika Birleşik Devletleri, 22 Eylül 2023, (Özet Bildiri)

4. Serum Cytokines Levels in Patients with Myasthenia Gravis and Their Changes After Treatment

ARSLAN D., ERGÜL ÜLGER Z., gökşen s., ESENDAĞLI G., ERDEM ÖZDAMAR S., TAN M. E., et al.

75th Annual Meeting of the American-Academy-of-Neurology (AAN), Boston, Amerika Birleşik Devletleri, 22 Nisan 2023, (Özet Bildiri)

5. MME MUTASYONUNA BAĞLI DEMİYELİNİZAN NÖROPATİ

Demirel Özbek E., ERGÜL ÜLGER Z., TAN M. E., ERDEM ÖZDAMAR S., KURT C. E.

58. Ulusal Nöroloji Kongresi, Antalya, Türkiye, 19 - 24 Kasım 2022, (Özet Bildiri)

6. The effect and challenges of nusinersen treatment in adult spinal muscular atrophy patients - preliminary results

Inan B., Bekircan-Kurt C. E., Kilinc M., Erdem-Ozdamar S., Tan E.

6th Congress of the European-Academy-of-Neurology (EAN), ELECTR NETWORK, 23 - 26 Mayıs 2020, cilt.27, ss.625, (Özet Bildiri)

7. Transthyretin Familial Amyloid Polyneuropathy (TTR-FAP): A Database Analysis

ERDOĞAN Ç., Bayrak A. O., ULUÇ K., Karli N., KOÇ A. F., ÖZTÜRK Ş., et al.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Kanada, 25 Nisan - 01 Mayıs 2020, cilt.94, (Özet Bildiri)

8. A novel ARMS-PCR assay for screening MT-TL1 mutations causing mitochondrial cytopathies

KILIÇ H. B., Bekircan Kurt C. E., HALİLOĞLU V. G., ERDEM ÖZDAMAR S., TOPALOĞLU H. A., KOCAEFE Y. Ç.

FEBS OPEN BIO, 1 - 11 Haziran 2019, cilt.9, ss.202, (Özet Bildiri)

9. Multimodal Assessment Of Intensive Care Unit-Acquired Weakness (ICU-AW) In Severe Acute Stroke Patients

İNAN B., KURT C. E., TEMUÇİN Ç. M., ARSAVA E. M., TOPÇUOĞLU M. A., ERDEM ÖZDAMAR S., et al.

2019 PNS Meeting, 22 - 26 Haziran 2019, (Özet Bildiri)